Skip to main content

Amedisys Inc

AMEDDelisted Aug 14, 2025
Industry
Services-Home Health Care Services
SEC CIK
0000896262

Amedisys Inc was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 321 institutions reported holding it in 13F filings for Q2 2025, worth $3.20B in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
321
Q2 2025, +19 vs. previous quarter
13F value
$3.20B
Reported value at the end of Q2 2025
Superinvestors holding
0
At the end of Q2 2025

From SEC filings, in USD.

Revenue, FY2024
$2.35B
No comparable prior period
Net income, FY2024
$43.2M
No comparable prior period
Free cash flow, FY2024
$215.1M
+63.5% year over year
Revenue, Q2 FY2025
$621.9M
+5.2% year over year

Revenue flow, FY2024

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Superinvestors holding AMED, Q2 2025

Go to the superinvestors tab

No superinvestor reported holding AMED at the end of Q2 2025.

Latest insider trades

See all insider trades

Open-market purchases and sales by Amedisys Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 9, 2025 (view filing)May 81 dayGuidroz AllysonChief Accounting OfficerSSale−374$96.00−$35.9K−4.4%8.11K after
Mar 6, 2025 (view filing)Mar 42 daysGuidroz AllysonChief Accounting OfficerSSale−2.04K$92.03−$187.8K−18.9%8.76K after
Mar 8, 2023 (view filing)Mar 35 daysLateNorth Michael PaulChief Information OfficerSSale−5.91K$86.43−$510.6K−58.7%4.16K after
Jun 27, 2022 (view filing)Jun 234 daysBohnert Denise M.Chief Compliance OfficerSSale−557$115.00−$64.1K−4.5%11.8K after
Apr 4, 2022 (view filing)Mar 296 daysLateKemmerly David LSee RemarksSSale−2.50K$177.31−$443.3K−13.3%16.3K after3 lots
Dec 2, 2021 (view filing)Nov 302 daysLechleiter Richard ADirectorPPurchase+1.00K$141.25+$141.3K+12.0%9.37K after
Sep 3, 2021 (view filing)Sep 12 daysPerkins Bruce DDirectorSSale−11.5K$183.00−$2.11M−39.2%17.9K after
Aug 4, 2021 (view filing)Aug 22 daysGerard ChristopherPresident & COOSSale−1.25K$261.24−$326.5K−3.2%37.9K after4 lots
Jul 6, 2021 (view filing)Jul 15 daysGerard ChristopherPresident & COOSSale−1.25K$250.90−$313.6K−3.1%39.1K after2 lots

Top 10 13F holders, Q2 2025

See all 321 holders

The largest institutional positions in Amedisys Inc at the end of Q2 2025; share changes are against Q1 2025.

Institutions holding AMED in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.3,345,633$329.2M0.01%+78,947+2.4%Added
Vanguard Group Inc3,041,392$299.2M0.00%−156,119−4.9%Reduced
Pentwater Capital Management LP1,715,084$168.7M2.15%+370,084+27.5%Added
FIL Ltd1,312,785$129.2M0.11%+433,785+49.3%Added
Alpine Associates Management Inc.1,096,920$107.9M5.78%+104,800+10.6%Added
State Street Corp1,067,613$105.0M0.00%+60,030+6.0%Added
Norges Bank902,135$88.8M0.01%+12,742+1.4%Added
UBS Group AG878,850$86.5M0.02%+244,349+38.5%Added
TIG Advisors, LLC856,753$84.3M4.60%+20,336+2.4%Added
Qube Research & Technologies Ltd790,548$77.8M0.11%+169,444+27.3%Added

3 members of Congress reported 5 trades in Amedisys Inc since 2020. Newest filings:

  1. Lisa C. McClain

    House · MI · Sep 12, 2025

    Sell$1K-$15K

  2. Lisa C. McClain

    House · MI · Aug 13, 2025

    Buy$1K-$15K

  3. Greg Gianforte

    House · MT · Nov 9, 2020

    Sell (partial)$1K-$15K

  4. Donna E. Shalala

    House · FL · Apr 27, 2020

    Sell$1K-$15K

  5. Donna E. Shalala

    House · FL · Apr 27, 2020

    Sell (partial)$1K-$15K